Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5%
The real-time PCR workflow has a capacity of up to 6,000 tests per day per system, and demonstrated 100% agreement with authorized nasopharyngeal assays
QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research
Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season
The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively
Across all populations, BNT162b2 administration was well tolerated with mild to moderate fever in fewer than 20% of the participants
Regeneron will distribute REGN-COV2 in the U.S. and Roche will be responsible for distribution outside the U.S.
The AccuPlex SARS-CoV-2 molecular controls kit is designed to measure day-to-day assay performance and contains positive materials
The collaboration is the first larger scale production run of Apta-1 as a non-GMP material, intended for use in GLP toxicology studies
The test outperforms other molecular tests with a low detection limit of 15 GEC/reaction (250 GEC/ml of sample) and a robust control system
The consortium aims to determine the dynamics, function and potential for therapeutic intervention of the RNA and protein structures of SARS-CoV-2
IgM assay has 95.51% positive predictive value even when disease incidence is only 3%
The new assays are designed to enable turnaround times for next-generation sequencing results of less than 24 hours
Nirsevimab is the first potential passive immunisation for infants to demonstrate sustained protection across the entire RSV season with a single dose
In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA
The high-throughput system enables laboratories to double or even triple their testing capacity
This powerful new solution aims to provide more accurate COVID-19 antibody detection
Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing
Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing
BLENREP is the fifth major medicine approval for GSK in 2020
Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes
The modular solution aims to deliver test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources
Exclusive interviews, new methods, free downloads, and much more to help you advance your work
87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus
